AI Model can Predict whether Crohn Disease will Recur After Surgery

Using an artificial intelligence (AI) tool that emulates how humans visualize and is trained to recognize and classify images, investigators constructed a model that predicts the postoperative recurrence of Crohn disease with high accuracy by evaluating histological images. The AI tool also revealed previously unrecognized differences in adipose cells and significant differences in the extent of mast cell infiltration in the subserosa, or outer lining of the intestine, comparing patients with and without disease recurrence. The findings appear in The American Journal of Pathology, published by Elsevier.

The 10-year rate of postoperative symptomatic recurrence of Crohn disease, a chronic inflammatory gastrointestinal disease, is estimated at 40%. Although there are scoring systems to evaluate Crohn disease activity and the existence of postoperative recurrence, no scoring system had been developed to predict whether Crohn disease might recur.

"Most of the analysis of histopathological images using AI in the past have targeted malignant tumors," explained lead investigators Takahiro Matsui, MD, PhD, and Eiichi Morii, MD, PhD, Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan. "We aimed to obtain clinically useful information for a wider variety of diseases by analyzing histopathology images using AI. We focused on Crohn disease, in which postoperative recurrence is a clinical problem."

Sixty-eight patients with Crohn disease who underwent bowel resection between January 2007 and July 2018 were included in the study. They were classified into two groups according to the presence or absence of postoperative disease recurrence within two years after surgery. Each group was sorted into two subgroups, one for training an AI model and the other for validation. For training, whole slide images of surgical specimens were cropped into tile images, labelled for presence or absence of postsurgical recurrence, and then processed by EfficientNet-b5, a commercially available AI model designed to perform image classification. When the model was tested with unlabeled images, the results indicated that the deep learning model accurately classified the unlabeled images according to the presence or absence of disease occurrence.

Next, predictive heat maps were generated to identify areas and histological features from which the machine learning model could predict recurrence with high accuracy. The images included all layers of the intestinal wall. The heatmaps showed that the machine learning model yielded correct predictions in the subserosal adipose tissue layer. However, in other areas, such as the mucosal and proper muscular layers, the model was less accurate. Images with the most accurate predictions were extracted from the test datasets of the non-recurrence and recurrence groups. Among these images, the best predictive results all contained adipose tissue.

Because the machine learning model achieved accurate predictions from images of subserosal tissue, the investigators hypothesized that subserosal adipose cell morphologies differed between the recurrence and the nonrecurrence groups. Adipose cells in the recurrence group had a significantly smaller cell size, higher flattening, and smaller center to center cell distance values than those in the nonrecurrence group.

"These features, defined as 'adipocyte shrinkage,' are important histological characteristics associated with Crohn disease recurrence," said Dr. Matsui and Dr. Morii.

The investigators also hypothesized that the differences in adipocyte morphology between the two groups were associated with some degree or type of inflammatory condition in the tissue. They found that the recurrence group had a significantly higher number of mast cells infiltrating the subserosal adipose tissue, indicating that the cells are associated with the recurrence of Crohn disease and the "adipocyte shrinkage" phenomenon.

To the investigators' knowledge, these findings are the first to link postoperative recurrence of Crohn disease with the histology of subserosal adipose cells and mast cell infiltration. Dr. Matsui and Dr. Morii observed, "Our findings enable stratification by prognosis of postoperative Crohn disease patients. Many drugs, including biologicals, are used to prevent Crohn disease recurrence, and proper stratification can enable more intensive and successful treatment of high-risk patients."

Kiyokawa H, Abe M, Matsui T, Kurashige M, Ohshima K, Tahara S, Nojima S, Ogino T, Sekido Y, Mizushima T, Morii E.
Deep Learning Analysis of Histologic Images from Intestinal Specimen Reveals Adipocyte Shrinkage and Mast Cell Infiltration to Predict Postoperative Crohn Disease.
Am J Pathol. 2022 Mar 28:S0002-9440(22)00106-7. doi: 10.1016/j.ajpath.2022.03.006

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...